Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Victhom Human Bionics Inc V.VHB

TSXV:VHB - Post Discussion

Victhom Human Bionics Inc > ***************U P D A T E***********
View:
Post by modulex on Feb 27, 2013 5:54pm

***************U P D A T E***********

Mrs. Tendland KARINE.TENDLAND@VICTHOM.COM says that she is on maternity leave and would be returning in January 2013.  She is either not back to work or has deliberately not updated her work documents as we are now at the end of February 2013.  As for the contact with Mrs. Nathalie Guilbert NATHALIE.GUILBERT@VICTHOM.COM, she has not responded to my February 26, 2013 e-mail yet.
 

February 26, 2013

Mrs. Tendland:

I am noticing that some Press Releases are no longer showing on the company's website WWW.VICTHOM.COM as well as management information, such as the name of the President/CEO and Board members.

Could you please update.

Luc Proulx

LPROEXP@HOTMAIL.COM

 

 
De : Karine Tendland <karine.tendland@victhom.com>
À : <LPROEXP@HOTMAIL.COM>
Envoyé le : mardi 26 février 2013 18h42
Objet : Absence du bureau : VICTHOM HUMAN BIONICS

Hello,

Please note that I am currently in maternity leave and I will be back in January 2013. Mrs. Nathalie Guilbert will assume the Director of finance's functions during this period. Please forward your email to nathalie.guilbert@victhom.com.

Thank you,

______________________________________________________________________________
 
In a separate piece of news, I have contacted on February 26, 2013, the President/CEO of a public company, being a competitor of Victhom.  The President/CEO replied to me as follows (translated from FRENCH to ENGLISH).
 
Hello Mr. Proulx:
 
Thank you for your e-mail.  Victhom is indeed in our field of business.  I can't unfortunately comment further.
 
Best regards.
 
Sent on the TELUS Mobility network with BlackBerry.
_____________________________________________________________________________
 
I suggest that all VICTHOM shareholders send an e-mail to: NORMAND.RIVARD@VICTHOM.COM to see what is happening?  If you dont get a reply, this will tell you that he is hiding somewhere and therefore we should warn the police for his arrest.
 
 
Normand Rivard
President and Chief Executive Officer
Victhom Human Bionics. Inc.  
Tél. : (438) 380-5244  
Téléc. : (438) 381-1530
normand.rivard@victhom.com
 
According to VICTHOM'S latest Press Release of November 23, 2012, the company has money in the amount of  $2,770,731.00 = $0.14/per share.  The company has of 19,297,654 common shares outstanding.
_____________________________________________________
Comment by ronz on Feb 27, 2013 7:31pm
Modulex,      The results of your inquires are exactly the same results that I had encountered. I have to admit that with my lack of any communicaion from their end in response to my e-mails, I have sold off a considerable portion of my holdings last month ad have come to the conclusion that the management team is going to potentially bleed the company dry of their cash in over ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities